Estimating lung cancer risk with exposure to environmental tobacco smoke. by Lubin, J H
Estimating Lung Cancer Riskwith Exposureto Environmental Tobacco Smoke
Jay H. Lubin
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland USA
Estimates of lung cancer in nonsmokers due to exposure to environmental tobacco smoke (ETS) in
the workplace or in the home may be developed in several ways. Estimates may be based on a)
models developed using the full range of data in smokers; b) models developed using data restricted
to smokers with a low smoking rate, for example, < 10 cigarettes per day; c) models developed
using data from studies of residential exposure to ETS of nonsmokers, with exposures based on
smoking rates of spouses; and d) models using data from studies of occupational exposure to ETS
of nonsmokers. Methods a and b require an estimate of cigarette equivalent exposure for ETS as
well as assumptions on the cigarette equivalent dose to target cells from ETS and on the
comparability of lung cancer risk per unit dose from smokers and nonsmokers. Summary relative
risks (RRs) and 95% confidence intervals (Cl) from ETS studies of nonsmokers with exposures
based on smoking patterns of spouses are 1.24 (1.1, 1.4) for females and 1.34 (1.0, 1.8) for males,
whereas the RR estimate for occupational ETS exposure and its 95% Cl is 1.39 (1.2, 1.7). Using RR
estimates for ETS exposure, cigarette equivalents for ETS range from 0.1 to 1.0, based on a range of
descriptive and biologically motivated models in active smokers; a cigarette equivalent is 0.2 based
on a comparison of log-linear trends in RR with number of cigarettes smoked per day in active
smokers and in spouses of nonsmokers. Key words: epidemiology, lung cancer, meta-analysis,
passive smoking, relative risk. - Environ Health Perspect 107(suppl 6):879-883 (1999).
http.//ehpnetl.niehs.nih.gov/docs/1999/suppl-6/879-873lubin/abstract.html
Models are used to synthesize complex
patterns of associations within data. In the
case of lung cancer risk with exposure to
environmental tobacco smoke (ETS) among
nonsmokers or with duration and rate ofcig-
arette use among smokers, models bridge the
gap between the needs ofrisk estimation and
the availability of data, as often there are
insufficient data to estimate with precision
relative risks (RRs) for every exposed sub-
group ofinterest.
Two types of modeling approaches have
been applied (1). In the descriptive approach,
statistical models are applied to epidemiologic
data and used to summarize lung cancer rates
as a function ofsmoking characteristics and
other covariates. For example, investigators
find that the RR oflung cancer increases with
duration and rate (number of cigarettes
smoked) ofcigarette use and decreases with
time since cessation ofsmoking (ofthe indi-
vidual, or in the case ofETS, ofthe spouse or
co-workers). In addition to those factors,
other potential risk factors include age at start
ofsmoking, age at risk, other lung diseases,
occupation, diet, and sex. Descriptive models
allow the evaluation ofa diverse set ofpoten-
tial risk factors with few a priori assumptions
about the form ofthe functional relationship
between risk and the covariates. Descriptive
models are developed one step at a time, with
the addition ofcovariates and the specification
oftheir functional forms based on formal sta-
tistical tests. Descriptive models are suffi-
ciently flexible that expected biologic effects of
exposure can be qualitatively or quantitatively
incorporated into the modeling. The validity
ofthe elements ofa model and the inclusion
ofspecific covariates can be directly evaluated
within the data. However, with limitations in
the amount and range ofdata, descriptive
models are often rather crude, yielding at best
a rough characterization ofdisease rates.
Biologically motivated models seek to
provide a link between disease risk and under-
lying biologic processes. The estimated para-
meters are then interpretable within the
mechanistic framework and may provide
meaningful biologic insights. Two biologically
motivated models that have been applied to
lung cancer data are the Armitage-Doll multi-
stage model (2) and the Moolgavkar-Knudsen
two-stage clonal expansion model (3).
Although biologically motivated models may
provide a link to disease processes, the biologic
basis ofthe model cannot be validated within
the epidemiologic data. Both descriptive and
biologically motivated models permit estima-
tion oflung cancer risks over a broad range of
smoking rates and durations, in particular at
levels of exposure comparable with ETS
exposure in nonsmokers.
Several methods are used to estimate lung
cancer risks with ETS exposure (Table 1).
Estimates of risk from ETS exposure in non-
smokers may be based on models developed
using the full range ofsmoking data or from
data on low-exposed smokers, for example,
those smoking < 10 cigarettes per day. The
restricted data are more directly relevant to
the range of ETS exposure encountered by
nonsmokers. Applicability of risk estimates
from models based on active smokers requires
that there is an estimate of cigarette
equivalent exposure in active smokers that is
related to ETS exposure, and the conse-
quences ofexposure from one cigarette equiv-
alent are the same in active smokers and in
those exposed to ETS. Puntoni et al. (4) esti-
mated an empirical, risk-based cigarette
equivalent by equating RRs in studies of
smokers with RRs in studies of ETS expo-
sure, specifically the results of Saracci and
Riboli (RR = 1.37 with 95% confidence
interval [CI] 1.20, 1.53) (5) and Tweedie
and Mengersen (RR = 1.17 with 95% CI
1.06, 1.28) (6). Puntoni et al. fitted six dif-
ferent mathematical models to summary data
on smokers from nine cohort studies, then
equated the predicted risk from the models to
the estimated RR for ETS exposure to obtain
estimates ofcigarette equivalents. The models
include the biologically motivated one-hit
model, the two-stage Moolgavkar-Knudsen
model, the Armitage-Doll multistage model,
and the logit, probit, and Weibull probability
models. These risk-based estimates suggest
that average ETS exposure is equivalent to
exposure of an active smoker to 0.21-0.43
cigarettes per day.
A number of reports tabulate the
constituents ofETS derived from sidestream
smoke and exhaled mainstream smoke (MS)
and the MS that is directly inhaled by the
smoker (7,8). The components of ETS are
qualitatively similar to those ofinhaled MS,
although there are quantitative differences.
On the basis of biochemical markers, ETS
exposure in nonsmokers is estimated to be
equivalent to active smokers consuming from
0.1 to as many as two cigarettes per day (8).
Whether this biologically equivalent exposure
in active smokers and in nonsmokers exposed
to ETS reflects an equal lung dose and
thereby an equal increment oflung cancer
risk is unclear.
Lung cancer risk can also be estimated
directly from studies of ETS exposure. Even
though many ofthe epidemiologic studies of
ETS consist of female nonsmokers, with
exposure based on smoking characteristics of
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Table 1. Methods and sources of data forestimating lung cancer riskfrom the exposure to ETS of nonsmokers.
Method Sources of data Comment
Modeling risks Studies ofcurrent and Models include the full range of data from ever smokers.
in current and former smokers and Relevance of RRs for ETS exposure depends on adjustment
former smokers nonsmokers of baseline RR in nonsmokers for ETS exposure, low-dose
extrapolation and onvalidity ofcigarette equivalents.
Modeling RRs in low- Studies of smokers with More directly applicable to the range of ETS exposures.
exposure smokers lowsmoking rate, e.g., Relevance depends on adjustment of baseline RR in non-
< 10 cigarettes per day smokers for ETS exposure and on validity of cigarette
equivalents for ETS exposure.
Modeling RRs for Studies of nonsmokers Range ofdata directly applicable to ETS exposure. Majority of
residential ETS exposed to ETS data derived from studies of nonsmoking females, with ETS
of nonsmokers exposure defined bysmoking habits in the spouse. Estimates
require adjustment of baseline RR for other ETS exposure
and for inclusion of smokers who claim to be nonsmokers.
Modeling RRs for Studies of nonsmokers Range of data directlyapplicable to ETS exposure. Estimates
occupational occupationally require adjustment forthe inclusion of smokers who claim
ETS exposure exposed to ETS to be nonsmokers and forthe assessment of occupational
exposures overtime.
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Figure 1. Funnel plot of environmental tobacco smoke
studies. Studies of nonsmoking females and males with
smoking spouses shown with open and solid squares,
respectively. Data from Hackshaw et al. (11).
spouses, there are also relevant data for males
and for occupational ETS exposure (9).
Estimating Lung Cancer Risk
from ETS Using Data from ETS
Studies
Epidemiologic studies that directly evaluate
excess lung cancer risk from ETS exposure
have two principal limitations: the excess risks
under investigation are small, on the order of
10-50%, and exposures are determined with
substantial misclassification, tending to reduce
RRs and study power. These limitations sug-
gest that definitive results from a single study,
even a large study, are unlikely. Thus, the
aggregation ofresults from multiple studies is
needed to havesufficient power to characterize
the risk from ETS exposure precisely.
Data from multiple studies can be
combined by pooling or bymeta-analysis. The
former approach involves acquiring data on
individuals from each study, with the individ-
ual as the unit ofanalysis. The latter approach
uses summary results, e.g., RRs and 95% CIs,
from published papers. Pooled analyses offer
greater flexibility for assessing confounding
factors and heterogeneity ofRRs within sub-
groups and across study populations.
Additional factors and subtle variations in
effects that cannot be evaluated in individual
studies can be analyzed in pooled data. The
pooling ofdiverse data sets, including studies
with potentially very different design proto-
cols, is a complex undertaking and to date no
large-scale pooling ofETS studies has been
published. Meta-analysis is generally easier to
carry out than data pooling, since data are
limited to published results, although the abil-
ity to analyze additional factors within studies
is limited. In the absence of uncontrolled
confounding, meta-analyses provide unbiased
estimates ofassociation.
Meta-Analysis ofETSExposureStudies
A number ofmeta-analyses ofETS exposure
and lung cancer risk have been conducted
(7,8,10-12). A recent review lists 37 ETS
studies of lung cancer, including 4 cohort
studies and 33 case-control studies (11).
These studies were conducted in nonsmoking
women whose spouses smoked; 9 ofthe 37
studies also include nonsmoking males with
smoking spouses. [Hackshaw et al. (11) list
two additional studies with results only for
females and males combined.] The studies
include a total of4,900 lung cancer cases
(5,095 cases in all 39 studies). The 1997 meta-
analysis by Hackshaw and colleagues is the
largest to date. For nonsmokers married to
smokers compared to nonsmokers married to
nonsmokers, the estimated RRs and 95% CIs
are 1.24 (1.13, 1.36) for females and 1.34
(0.97, 1.84) for males, and 1.27 (1.17, 1.38)
combined. Results are consistent across the
various studies in the meta-analysis, and overall
RRs are homogeneous. There is concern that
study results may vary over time because of
population drift or publication bias. A plot of
the summary RR by calendar year reveals no
variation ofresultswithcalendar time (11).
Hackshaw et al. (11) report on a
dose-response analysis for studies with avail-
able data. Sixteen studies of nonsmoking
females with a smoking spouse provide RRs
by number ofcigarettes smoked per day by
the spouse. Eleven studies report RRs bycate-
gories ofnumber ofyears a women lived with
a smoking spouse. For both exposure meas-
ures, RRs increase approximately log-linearly
with number of cigarettes smoked per day
and with duration ofexposure.
Hackshaw and colleagues (11) also
consider the problem of the effects ofvari-
ous types of bias on the summary estimate
of RR for ETS exposure. They consider
a) misclassification bias from including
current or former smokers as nonsmokers;
b) exposure to ETS from other, nonspouse
sources in the referent group of nonex-
posed; and c) confounding by low fruit and
vegetable consumption. They conclude that
the effects of bias from overestimation of
RR from a and the underestimation of RR
from b are likely to balance, and that any
possible confounding from c is minimal.
Their adjustments result in little practical
change in the overall estimated summary
RR from ETS exposure.
Critics raise the possibility that results
may be influenced by publication bias, where
studies with null results or negative results
are less likely to be published. Figure 1 shows
a funnel plot of the study-specific RRs for
ETS exposure on a log scale by the standard
error ofln(RR). Variation in study estimates
due to random statistical error results in a
funnel pattern with an increasing spread of
points with increasing standard error. The
figure provides little evidence of a publica-
tion bias, although there is some suggestion
ofa dearth ofestimates from smaller or less
powerful studies (large standard errors) with
null results.
In the meta-analysis ofHackshaw et al.,
there is no overall statistically significant het-
erogeneity in the results from the ETS
studies. The radial plot, where standardized
coefficients are plotted against their inverse
standard errors, illustrates study variability
(13). Estimates from ETS and lung cancer
studies are shown in Figure 2. Points nearer
the origin are measured with greater uncer-
tainty [the inverse standard error is small,
and the standardized ln(RR) is small],
whereas points away from the origin are esti-
mated with greater confidence. The solid line
represents the weighted estimate of the
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Figure 2. Radial plot of results from environmental
tobacco smoke studies of nonsmokers with smoking
spouses. Summary relative risks (solid line) and 95%
confidence intervals (dotted lines) are 1.27 (1.1, 1.4) and
are equal to the slopes of the lines. Data from
Hackshaw et al. (11).
summary ln(RR) and the dotted lines its
95% CI. Points markedly outside the area
between the dotted lines are outliers relative
to the summary estimate. The plot suggests
substantial variability in the studies over the
entire range ofstudy weights. This variability
may be due to differences among studies in
the level of ETS exposure, and hence the
observed RRs; large variations within study,
due perhaps to limited ranges ofexposure;
and exposure misclassification. Using a ran-
dom effects model (1), a random effects
adjustment for the individual RR estimates
results in extreme shrinkage ofthe study-spe-
cific RRs toward the overall weighted mean
(not shown), which again suggests large
variability among studies.
Assumptions are needed to use results
from ETS studies of nonsmokers (mainly
females) with smoking spouses to estimate
risks for occupational ETS exposure.
Although there is little reason to suspect fun-
damental differences in the composition of
ETS exposure at the workplace, assumptions
are needed to relate the amount ofETS expo-
sure at home and at the workplace.
Alternatively, RR estimates oflung cancer can
be based on studies ofoccupational ETS
exposure directly, such as those provided in a
recent meta-analysis of 14 occupational ETS
studies (12).
There are 14 published studies with useful
information (12). Wells argues that exposure
assessments in studies ofoccupational ETS
are subject to uncertainties not affecting the
spousal studies (job mobility, variation in
occupational environment due to worker
turnover, workplace changes over time, the
inability of surrogate respondents to recall
accurately the ETS environment ofdeceased
subjects), and therefore studies should satisfy
strict inclusion criteria before acceptance into
any meta-analysis. Wells specifies the follow-
ing criteria for inclusion ofstudies: a) avail-
ability ofa minimum exposure history; b) no
more than 50% surrogate response; c) some
level ofexposure quantification beyond little
or minimal ETS exposure; d) no large non-
environmental exposure to tobacco smoke;
e) for cohort studies, results only from non-
smokers; andf) some check on the CIs of
RRs. Ofthe 14 studies, only 5 studies satisfy
the eligibility criteria. Reasons for rejecting
studies include a high percentage ofsurrogate
responders, current exposures only, inclusion
offormer smokers, and the presence ofheavy
exposure from coal-heating fumes. In the 5
studies there are 835 lung cancer cases, 794
females and 41 males. The combined RR and
95% CI are 1.39 (1.15, 1.68) for all studies
and 1.43 (1.15, 1.78) for U.S. studies. Wells
also examines results by categories ofduration
ofworkplace ETS exposure. He finds a statis-
tically significant increasing trend with dura-
tion (p < 0.001). Relative to no occupational
ETS, RRs are 1.46, 1.55, and 2.08 for 1-15,
15-30, and > 30 years ofexposure.
There have been several previous meta-
analyses ofoccupational ETS exposure, with
results that fail to identify an excess risk from
occupational ETS exposure (14-17). Wells
argues that these authors failed to consider
important errors in the studies. These errors
include the misspecification of CIs in one
study because ofan analytic or a publication
error that resulted in the (negative) study
receiving too much weight, and an erroneous
RR that changed an estimate from 1.1 to
1.2. Wells claims that correcting these errors
largely explains the discrepancies between the
previous meta-analyses and his own.
RiskModels forLungCancerwith ETS
Exposure
There has been little fitting of risk models
directly to data from studies of ETS. As
described above, Hackshaw and colleagues
examined the RR relationship by categories
of spouses' smoking rate and duration of
exposure (11). They found an increasing RR
trend with both factors. For the log-linear
model RR(x) = exp(Px), they estimate 1B as
0.021, or a RR of 1.23 for exposure to 10
cigarettes per day. Because there has been lit-
tle quantitative modeling of ETS data in
houses or in the workplace, there has been
little or no assessment offactors that might
modify the ETS lung cancer association,
which could be compared to results in smok-
ers. Factors that could be evaluated include
rate and duration of ETS exposure, age at
exposure, age at risk, time since cessation of
ETS exposure, and sex.
Estimating Lung Cancer Risk
from ETS Using Data from
Cigarette Smokers
Regression models developed using the full
range of exposures in active smokers or using
only data restricted to low-exposure rates, for
example, 1-10 cigarettes per day, can provide
risk estimates from ETS exposure in non-
smokers. If ETS exposure is properly
expressed through cigarette equivalents, and if
the health consequences of a cigarette equiva-
lent are the same for those exposed to ETS
and for active smokers, than the observed RRs
for low-exposure-rate smokers estimate the
consequences ofETS in exposed nonsmokers.
Estimating RiskofLungCancerfrom
Low-Exposure DatainSmokers
Table 2 and Figure 3 summarize results from
studies with RRs for active smokers for cate-
gories at or below 10 cigarettes per day relative
to those ofnonsmokers. Nearly all estimated
RRs forlow exposures are above one, and there
is no evidence of a threshold below which
exposures do not increase risk oflung cancer.
These RRs are generallyconsidered to underes-
timate effects relative to effects for those who
were truly nonexposed, as the referent group
for the RRs includes persons with some ETS
exposure. Sources of potential bias include
smokers who incorrectly claim to be non-
smokers (increasing the baseline odds and
decreasing the RRs), and nonsmokers who are
exposed to substantial amounts ofunmeasured
ETS exposure (increasing the apparent effects
oftheir exposure). Using arguments similar to
those in Hackshaw et al. (11), approximations
ofthedegree ofbias could be obtained.
The studies in Table 2 do not always
provide information on standard errors ofthe
RR or on category-specific CIs, so the follow-
ing weighted regression analysis uses numbers
of lung cancer cases, when available, or
expected numbers ofcases based on the British
doctors' study as weights. A linear model,
RR(x) = 1 + Ox, and log-linear model RR(x) =
exp(,Bx) were fitted to the data (Figure 3).
Estimating RiskofLungCancer in
Cigarette Smokers: Descriptive Models
For developing descriptive models, analyses of
data in smokers generally focus on smoking
history without considering other lung cancer
risk factors. Analyses find an increase in RRs
with duration and rate ofcigarette use and a
decline in RRs with years since cessation of
smoking (18). Analyses also evaluate the risk
associated with other aspects ofsmoking, such
as nonfiltered/filtered cigarettes, high-tar/low-
tar cigarettes, the effects ofswitching from
nonfiltered/high-tar cigarettes to filtered/low-
tar cigarettes, types oftobacco, and depth and
frequency of inhalation of tobacco smoke.
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of cigarettes smoked per day for studies with low-expo-
sure categories (< 10 cigarettes perday).a
Study Cigarettes/
population day
ACS 25-state 0
study (27) 1-9
British doctors' 0
study (28) 1-14
Swedish 0
study(29) 1-7
8-15
U.S. veterans 0
study (30) 1-9
ACS nine-state 0
study (31) 1-9
Canadian veterans 0
study(32) 1-9
European case- 1-4
control study (33) 5-9
Cuba (34) 0
1-9
ACS, American Cancer Society. 'Data
Environmental Protection Agency(8).
Relative risk
Males Females
1.00 1.00
4.62 1.3
1.00 1.00
7.80 1.28
1.00 1.00
2.30 1.80
8.80 11.3
1.00
3.89
1.00
8.00
1.00
9.50
2.03 0.87
2.90 2.29
1.00 1.00
5.40 4.70
3adapted from U.S.
0 2 4 6 8 10 12
Cigarettes perday
Figure 3. Relative risks by number of cigarrettes per
day, together with estimated linear and log-linear mod-
els, and predictions from Doll and Peto (19) (dashed
line) and Darby and Pike (22) (dotted line).
Table 3. Estimated relative increase in cellular event
rates for multistage model applied to relative risks of
lung cancer among cigarette smokers.a
Relative increase due to smoking
Cigarettes/day First stage Penultimate stage
1-10 0.7 2.8
1 1-20 2.5 5.0
21-30 3.5 6.3
>30 4.0 7.0
aData from Brown and Chu (23).
However, a single, broad-based descriptive
model for lung cancer risk that includes a
comprehensive, quantitative characterization
ofall ofthese diverse smoking-related risk fac-
tors, and other factors such as sex and occu-
pational exposures, has not been developed.
Using 20 years ofdata from the British
doctors' study, Doll and Peto fit various
models to data from lifelong nonsmokers and
from continuing, cigarette-only smokers who
maintained an approximately constant expo-
sure rate (19). Although the authors are
guided by the multistage model for lung
cancer, their approach is essentially descrip-
tive, concentrating on lung cancer rates for
ages 40-79 years. Standardizing for age, the
incidence of lung cancer increases with
approximately the square ofexposure rate.
Standardizing for exposure rate, the incidence
increases with duration ofsmoking, charac-
terized as age minus 22.5, to the 4.5th power.
The authors note that the fit for the duration
models is similar regardless ofthe number of
years between 0 and 34 that are subtracted
from age. The model selected to represent the
annual incidence of lung cancer for the
British doctors is:
0.273 x 10-12 (cigarettes/day + 6)2
(age 22.5)4.5
This model suggests that for a fixed age at
risk, the RR as a function ofnumber ofciga-
rettes smoked per day (x) and relative to non-
smokers is described by RR(x) = (x+ 6)2/36.
This curve fits the RRs for low exposures
quite well (Figure 3).
Estimating RiskofLung Cancer in
Cigaette Smokers: Biologicaily
MotivatedModels
The Armitage-Doll multistage model assumes
that a single cell generates a malignant tumor
after undergoing k, distinct, ordered, heritable
transformations (2,20,21). As a consequence
ofthe multistage model, the background inci-
dence rate at age t is proportional to tll, and
a plot oflog-incidence against log-age results
in a linear function with slope k-l. Based on
data from nonsmokers, the incidence rate
increases approximately with the 4th power of
age, suggesting five stages in the carcinogenic
process (22). Among smokers, incidence
increases more rapidly with age; however,
when incidence is plotted against duration of
exposure, incidence increases again with
approximately the 4th power. The relation-
ship between incidence and the square of
smoking rate is interpreted as evidence that
smoking affects more than one stage ofthe
carcinogenesis process (22).
Using the Armitage-Doll model, Day and
Brown formally describe how observed
patterns of excess risk by age at first exposure,
duration ofexposure, and time since exposure
are related to stage ofaction. Inparticular,they
present equations for excess risk patterns asso-
ciated with exposure that acts at the first stage
and/or the penultimate stage ofthe carcino-
genic process (20). Brown and Chu apply
these equations in an analysis of a large
European case-control study oflung cancer to
show that smoking acts as both an early-stage
and a late-stage carcinogen (23). They con-
sider two RR patterns: variation ofthe RRs
with age started smoking among continuing
smokers, and variation ofthe RRs with time
since cessation ofsmoking among former
smokers. In nonsmokers and continuing
smokers, RRs decline with age started smok-
ing, after adjusting for age at interview, smok-
ing rate, filtered and nonfiltered cigarette use,
and other factors. This pattern is indicative of
a carcinogen that acts at an early stage of a
multistage process. Among continuing and
former cigarette smokers, RRs decrease with
time since cessation ofsmoking, afteradjusting
for age at interview, smoking rate, duration of
smoking, filtered and nonfiltered cigarette use,
and other factors. This pattern is indicative of
a carcinogen that acts at a late stage. Brown
and Chu also note that RRs with time since
cessation ofsmokingstopdeclining after about
20 years and maintain a plateau. This pattern
suggests that smoking affects both early and
late stages, with the decline reflectinglate-stage
effects and the leveling offreflecting residual
first-stage effects. Table 3 shows that at low
smoking rates, smoking plays a relatively
greater role as a penultimate-stage carcinogen
than as afirst-stagecarcinogen. There has been
no application ofthe Armitage-Doll model
directly to data on ETS exposures to evaluate
the ETS exposure as an early-stage and/or late-
stage carcinogen. Nonetheless, Brown and
Chu's analysis suggests that ETS exposure as a
late-stage promoter may have an enhanced
impact in occupational settings where other
lungcarcinogens are present.
Results similar to those ofBrown and Chu
(23) are obtained by Darby and Pike (22) in
theirfitting oftheArmitage-Doll model to the
British doctors' data. Darbyand Pike use their
derived model to estimate RRs forvarious lev-
els ofcigarettes per day (Table 4). Note that
these estimates are not adjusted for the possi-
ble effects ofETS exposure among nonsmok-
ers. The predicted RRs in the table suggest a
substantial level oflung cancer risk from ETS
exposure. In addition, whereas duration of
exposure is a potent factor in determining
risks among smokers (e.g., risk increases with
the 4th power ofduration), the impact of
duration ofETS exposure is relatively less at
low exposure rates. The RR with exposure to
1 cigarette perday increases from 1.46 to 1.77
with 20 years' additional exposure (Table 4).
In contrast, based on the Armitage-Doll
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Table 4. Relative risk of lung cancer at 65 years of age
for ETS exposure in cigarette equivalents per day.a
Equivalent Exposed Exposed Exposed
cigarettes (0-65years (20-65 years (0-20 years
per day of age) of age) ofage)
0.00 1.00 1.00 1.00
0.10 1.07 1.04 1.02
0.20 1.14 1.09 1.05
0.25 1.17 1.11 1.06
0.50 1.36 1.22 1.11
1.00 1.77 1.46 1.23
1.50 2.23 1.71 1.34
2.00 2.75 1.97 1.46
3.00 3.95 2.52 1.69
4.00 5.36 3.13 1.93
5.00 6.98 3.78 21.6
'Data based on the Armitage-Doll model fitted to the British
doctors' data (22).
model, for 20 cigarettes per day the excess
RRs for similar duration ofexposures would
predict a 4-fold increase (22). Figure 3
includes the Darby and Pike predictions (dot-
ted line) and shows that the fitted estimates
from the multistage model are similar to RRs
for very low smoking rates from a variety of
epidemiologic studies.
The Moolgavkar-Knudsen two-stage clonal
expansion model incorporates two principal
features: transition oftarget stem cells into
cancer cells through an intermediate stage in
two rate-limiting and heritable steps, and
growth and differentiation ofnormal target
and intermediate cells (3,24). This model dif-
fers from the Armitage-Doll model by allow-
ing the clonal expansion ofthe intermediate
cells. Moolgavkar and colleagues (24) apply
the two-stage model to the British doctors'
data, and confirm the earlier conclusion by
Doll and Peto that lung cancer incidence
increases approximately with the square ofthe
smoking rate. However, Moolgavkar et al. dis-
pute the conclusion that smoking duration is
more important than smoking rate in deter-
mining level of risk. Under the two-stage
model, the relative importance ofsmoking rate
and smoking duration depends on the final
model selected. With one set ofparameter esti-
mates and for ages over 45 years, predicted
lung cancer risk for smoking 40 cigarettes per
day for 10 years results in a greater risk than
smoking 20 cigarettes per day for 20 years,
suggesting that smoking rate is a more impor-
tant determinant of risk than duration of
smoking. For a second set ofmodel parameter
estimates, which fit the doctors' data equally
well, the predicted risks are reversed, suggest-
ing a greater role for duration ofsmoking.
Thus, under the two-stage model, the British
doctors' data are consistent with either smok-
ing rate or smoking duration playing a domi-
nant role. Moolgavkar et al. point out that
Whittemore (25) fits a model to the doctors'
data that includes cumulative exposure and
finds that the model fits as well as a model that
includes smoking rate and duration separately.
Table 5. Estimates of cigarette equivalents.
Source Range
Doll and Peto (19) 0.5-1.oa
Darby and Pike (22) 0.440.8a
Puntoni et al. (4) 0.2-0.4a
Hackshaw et al. (11) 0.2-0.31
U.S. EPA(8) 01-2.01
Linear model for < 10 cigarettes/day data 0.52.1a,c
Log-linear model for < 10 cigarettes/ 0.2-0.9ac
day data
Comparison of log-linear models 0.07-0.14d
U.S. EPA, U.S. Environmental Protection Agency. aRange derived
from 95% Cl for combined RR of ETS exposure. bRange based on
biologic markers of cotinine/nicotine. cRange includes 95% Cl of
model parameter estimate. dComparison of model parameters
for cigarettes/day for active smokers (Figure 3) and ETS expo-
sure [Hackshaw et al. (1111.
Moolgavkar et al. conclude that because of
limited data there is substantial indetermi-
nancy in the doctors' data and a variety of
interpretations are consistentwith the data.
In a joint analysis ofthe British doctors'
data and data from a cohort of Colorado
Plateau uranium miners exposed underground
to radioactive radon, Moolgavkar et al. (26)
find that the smoking effects are similar in the
two populations. They conclude that cigarette
smoke affects the first-stage mutation rate and
the kinetics ofintermediate cell division.
Summary
There are several ways of deriving RR
estimates due to ETS exposure. Based on a
RR of 1.27 for exposure to ETS, estimates of
cigarette equivalents are similar using a) a
variety of descriptive models over the full
range ofdata in smokers or in data restricted
to low-exposed smokers, or b) biologically
motivated models (Table 5). Estimates ofcig-
arette equivalents range from 0.1 to 1.0 ciga-
rettes per day. This range is consistent with a
comparison ofmodel-based estimates of RR
of 8.17 for 10 cigarettes per day in active
smokers and of 1.23 for ETS exposure to 10
cigarettes per day-a ratio of0.2. The consis-
tency of estimates using diverse sources of
data and approaches provides confidence in
the magnitude ofthe estimated ETS effects.
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